Millipore Sigma Vibrant Logo

371206 Dkk-1, His•Tag®, Mouse, Recombinant

Dkk-1, His•Tag®, Mouse, Recombinant, consists of amino acids 30-272, fused at the C-terminus to a His•Tag® sequence, and expressed in NS0-dervied mouse myeloma cells.

Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.
View Products on Sigmaaldrich.com
371206
Ver precios y disponibilidad

Descripción

Replacement Information

Tabla espec. clave

Purity
≥95% by SDS-PAGE

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
371206-10UG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 Frasco de vidrio 10 μg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      Description
      OverviewRecombinant, murine Dickkopf related protein-1 (Dkk-1), consisting of amino acids 30-272, fused at the C-terminus to a His•Tag® sequence, and expressed in NS0-dervied mouse myeloma cells. Dkk-1 is a well-documented antagonist of the Wnt signaling pathway. The balance between Dkk-1 inhibition and Wnt signaling is essential for bone formation and homeostasis.
      Catalogue Number371206
      Brand Family Calbiochem®
      References
      ReferencesPinzone, J.J. et al. 2009. Blood 113, 517.
      Li, J. et al. 2006. Bone 36, 754.
      Morvan, F. et al. 2006. J. Bone Miner. Res. 21, 934.
      Niehrs, C. 2006. Oncogene 25, 7469.
      Verani, R. et al. 2006. J. Neurochem. 101, 242.
      Cappuccio, I. et al. 2005. J. Neurosci. 25, 2647.
      Kemp, C. et al. 2005. Dev. Dyn. 233, 1064.
      Adamska, M. et al. 2004. Dev. Biol. 272, 134.
      Bullock, C.M. et al. 2004. Mol. Pharmacol. 65, 582.
      Mao, B. et al. 2002. Nature 417, 664.
      Mao, B. et al. 2001. Nature 411, 321.
      Glinka, A. et al. 1998. Nature 391, 357.
      Product Information
      FormLyophilized
      FormulationLyophilized from 0.2 µm filtered PBS, BSA.
      Quality LevelMQ100
      Applications
      Biological Information
      Biological activityND₅₀: 0.2-1 µg/ml as measured by the inhibition of Wnt-3a-induced alkaline phosphatase production in MC3T3-E1 mouse osteoblastic cells.
      Reduction of Axis-inducing activity: 60-100% reduction (using 1 ng rmDkk-1 per embryo) in the number of secondary axes produced in the presence of 10-20 pg Xwnt-8 mRNA using early Xenopus embryos.
      Purity≥95% by SDS-PAGE
      Physicochemical Information
      ContaminantsEndotoxin: ≤1.0 EU/µg protein
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Regulatory Review
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      371206-10UG 04055977191783

      Documentation

      Dkk-1, His•Tag®, Mouse, Recombinant Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      Dkk-1, His•Tag®, Mouse, Recombinant Certificados de análisis

      CargoNúmero de lote
      371206

      Referencias bibliográficas

      Visión general referencias
      Pinzone, J.J. et al. 2009. Blood 113, 517.
      Li, J. et al. 2006. Bone 36, 754.
      Morvan, F. et al. 2006. J. Bone Miner. Res. 21, 934.
      Niehrs, C. 2006. Oncogene 25, 7469.
      Verani, R. et al. 2006. J. Neurochem. 101, 242.
      Cappuccio, I. et al. 2005. J. Neurosci. 25, 2647.
      Kemp, C. et al. 2005. Dev. Dyn. 233, 1064.
      Adamska, M. et al. 2004. Dev. Biol. 272, 134.
      Bullock, C.M. et al. 2004. Mol. Pharmacol. 65, 582.
      Mao, B. et al. 2002. Nature 417, 664.
      Mao, B. et al. 2001. Nature 411, 321.
      Glinka, A. et al. 1998. Nature 391, 357.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision22-June-2011 RFH
      DescriptionRecombinant, murine Dickkopf related protein-1 (Dkk-1), consisting of amino acids 30-272, fused at the C-terminus to a His•Tag® sequence, and expressed in NS0-dervied mouse myeloma cells. Dkk-1 is a well-documented antagonist of the Wnt signaling pathway. The balance between Dkk-1 inhibition and Wnt signaling is essential for bone formation and homeostasis.
      FormLyophilized
      FormulationLyophilized from 0.2 µm filtered PBS, BSA.
      Purity≥95% by SDS-PAGE
      ContaminantsEndotoxin: ≤1.0 EU/µg protein
      Biological activityND₅₀: 0.2-1 µg/ml as measured by the inhibition of Wnt-3a-induced alkaline phosphatase production in MC3T3-E1 mouse osteoblastic cells.
      Reduction of Axis-inducing activity: 60-100% reduction (using 1 ng rmDkk-1 per embryo) in the number of secondary axes produced in the presence of 10-20 pg Xwnt-8 mRNA using early Xenopus embryos.
      SolubilityReconstitute to 100 µg/ml with sterile PBS containing ≥1% human or bovine serum albumin.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Toxicity Regulatory Review
      ReferencesPinzone, J.J. et al. 2009. Blood 113, 517.
      Li, J. et al. 2006. Bone 36, 754.
      Morvan, F. et al. 2006. J. Bone Miner. Res. 21, 934.
      Niehrs, C. 2006. Oncogene 25, 7469.
      Verani, R. et al. 2006. J. Neurochem. 101, 242.
      Cappuccio, I. et al. 2005. J. Neurosci. 25, 2647.
      Kemp, C. et al. 2005. Dev. Dyn. 233, 1064.
      Adamska, M. et al. 2004. Dev. Biol. 272, 134.
      Bullock, C.M. et al. 2004. Mol. Pharmacol. 65, 582.
      Mao, B. et al. 2002. Nature 417, 664.
      Mao, B. et al. 2001. Nature 411, 321.
      Glinka, A. et al. 1998. Nature 391, 357.